BibTex RIS Cite

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

Year 2013, Volume: 26 Issue: 3, 176 - 177, 30.09.2015
https://doi.org/10.5472/MMJ.2013.02828.1

Abstract

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

References

  • Shreve P, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.
  • Cook GJR, Fogelman I, Maisey M. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;24:308-14. doi: 10.1016/S0001-2998(96)80006-7
  • Bischof-Delaloye A, Wahl RL. How high a level of FDG abdominal activity is considered normal? J Nucl Med 1995; 36(suppl):106P. Horton KM, Fishman EK. Helical CT of the stomach: evaluation with water as an oral contrast agent. AJR 1998;171:1373-6. doi: 10.2214/ ajr.15.9798881
  • Mijin Y, Hyun S C, Eunhye Y, et al. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med 2005;46:953-7.

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

Year 2013, Volume: 26 Issue: 3, 176 - 177, 30.09.2015
https://doi.org/10.5472/MMJ.2013.02828.1

Abstract

-

References

  • Shreve P, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.
  • Cook GJR, Fogelman I, Maisey M. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;24:308-14. doi: 10.1016/S0001-2998(96)80006-7
  • Bischof-Delaloye A, Wahl RL. How high a level of FDG abdominal activity is considered normal? J Nucl Med 1995; 36(suppl):106P. Horton KM, Fishman EK. Helical CT of the stomach: evaluation with water as an oral contrast agent. AJR 1998;171:1373-6. doi: 10.2214/ ajr.15.9798881
  • Mijin Y, Hyun S C, Eunhye Y, et al. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med 2005;46:953-7.
There are 4 citations in total.

Details

Primary Language English
Journal Section Articles
Authors

Salih Özgüven This is me

Publication Date September 30, 2015
Published in Issue Year 2013 Volume: 26 Issue: 3

Cite

APA Özgüven, S. (2015). Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Medical Journal, 26(3), 176-177. https://doi.org/10.5472/MMJ.2013.02828.1
AMA Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. September 2015;26(3):176-177. doi:10.5472/MMJ.2013.02828.1
Chicago Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal 26, no. 3 (September 2015): 176-77. https://doi.org/10.5472/MMJ.2013.02828.1.
EndNote Özgüven S (September 1, 2015) Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Medical Journal 26 3 176–177.
IEEE S. Özgüven, “Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?”, Marmara Med J, vol. 26, no. 3, pp. 176–177, 2015, doi: 10.5472/MMJ.2013.02828.1.
ISNAD Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal 26/3 (September 2015), 176-177. https://doi.org/10.5472/MMJ.2013.02828.1.
JAMA Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. 2015;26:176–177.
MLA Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal, vol. 26, no. 3, 2015, pp. 176-7, doi:10.5472/MMJ.2013.02828.1.
Vancouver Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. 2015;26(3):176-7.